| Market Cap | ₹2,516Cr |
| ROE | 8.79% |
| P/E Ratio(TTM) | 31.36 |
| EPS(TTM) | 24.73 |
| P/B Ratio | 2.85 |
| Dividend Yield | 0.35% |
| Industry P/E | 67.33 |
| Book Value | 272.16 |
| Debt to Equity | 0.23 |
| Face Value | 5 |
| Parent Organisation | Krsnaa Diagnostics |
| Managing Director | Ms. Pallavi Bhatevara |
| NSE Symbol | KRSNAA |
| FUND NAME | AUM(%) |
|---|---|
| Tata Small Cap Fund Direct Growth | 1.67% |
| Bandhan Small Cap Fund Direct Growth | 0.27% |
| Tata India Pharma & Healthcare Fund Direct Growth | 0.08% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 48.69 | ||
| Metropolis Healthcare | NA (0.00%) | 66.72 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 67.14 | ||
| Thyrocare Technologies | NA (0.00%) | 58.51 |